Search Results
Search for other papers by Samrin Kagdi in
Google Scholar
PubMed
Search for other papers by Sulayman A Lyons in
Google Scholar
PubMed
Search for other papers by Jacqueline L Beaudry in
Google Scholar
PubMed
Introduction Glucose-dependent insulinotropic polypeptide (GIP) is secreted as a 42-amino acid peptide from the K cells of the upper small intestine in response to meal ingestion ( Ugleholdt et al. 2006 ). Initially identified as gastric
Search for other papers by Ryan A Lafferty in
Google Scholar
PubMed
Search for other papers by Peter R Flatt in
Google Scholar
PubMed
Search for other papers by Victor A Gault in
Google Scholar
PubMed
Search for other papers by Nigel Irwin in
Google Scholar
PubMed
Introduction Glucose-dependent insulinotropic polypeptide (GIP) is a 42-amino acid polypeptide hormone secreted from intestinal K-cells of the duodenum and proximal jejunum ( Buchan et al. 1978 ). GIP was discovered in 1969, through
Search for other papers by B Messenger in
Google Scholar
PubMed
Search for other papers by MN Clifford in
Google Scholar
PubMed
Search for other papers by LM Morgan in
Google Scholar
PubMed
Gastrointestinal peptides, including insulin, glucagon and glucose-dependent insulinotropic polypeptide (GIP) have previously been reported in salivary glands. Recent evidence has suggested they might influence postprandial macronutrient metabolism. This study therefore investigated and compared postprandial hormone concentrations in saliva and plasma to determine whether their secretion was influenced by oral food stimuli. In a within-subject randomised cross-over comparison of hormone concentrations in plasma and saliva following a mixed meal, 12 subjects were given two 1708 kJ mixed meals. On one occasion the meal was chewed and swallowed (swallowed meal), on the other it was chewed and expectorated (sham-fed meal). Salivary and plasma levels of immunoreactive insulin, GIP and glucagon-like peptide-1 (GLP-1), total protein, alpha-amylase, glucose and non-esterified fatty acid were measured before and for 90 min following the meals. Saliva total protein and alpha-amylase rose following both meals, indicating that the stimulus for salivary protein release is related to the presence of food in the mouth. GLP-1 was not detected in saliva. Fasting salivary insulin levels were lower in saliva than plasma (28+/-6 vs 40+/-25 pmol/l respectively). Both increased following the swallowed meal but the rise in saliva was slower and less marked than in plasma (peak levels 96+/-18 and 270+/-66 pmol/l for saliva and plasma respectively, P<0.01). Both were unchanged following the sham-fed meal. GIP was detected in saliva. Fasting GIP levels were significantly higher in saliva than plasma (183+/-23 compared with 20+/-7 pmol/l, P<0.01). They decreased in saliva following both swallowed and sham-fed meals to nadirs of 117+/-17 and 71+/-12 pmol/l respectively, but rose following the swallowed meal to peak levels of 268+/-66 pmol/l. These findings are consistent with insulin in saliva being an ultrafiltrate of that circulating in blood, but GIP in saliva being the product of local salivary gland synthesis, whose secretion is influenced, directly or indirectly, by oral stimuli. The function of salivary GIP is unknown, but we speculate that it may play a role in the regulation of gastric acid secretion in the fasting state.
Search for other papers by A Trumper in
Google Scholar
PubMed
Search for other papers by K Trumper in
Google Scholar
PubMed
Search for other papers by D Horsch in
Google Scholar
PubMed
Glucose-dependent insulinotropic polypeptide (GIP) acts as a glucose-dependent growth factor for beta-cells. Here we show that GIP and glucose also act synergistically as anti-apoptotic factors for beta-cells, using the well-differentiated beta-cell line, INS-1. Mitogenic and anti-apoptotic signaling of GIP were dependent upon pleiotropic activation of protein kinase A (PKA)/cAMP regulatory element binder (CREB), mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3-kinase)/PKB signaling modules. The signaling modules activated by GIP were dependent on glucose metabolism and calcium influx and were tightly linked by multiple activating and inhibiting cross-talk. These interactions included: (i) a central role of tyrosine phosphorylation for stimulation of PKA/CREB, MAPK and PI3-kinase/PKB, (ii) inhibition of PKA/CREB by the MAPK pathway at the level of MAPK kinase-1 or downstream, (iii) activation of MAPK signaling by PI3-kinase and PKA at the level of extracellular-signal regulated kinase 1/2 or upstream, and (iv) activation of PKB by MAPK and PKA signaling at the level of PKB or upstream. Furthermore, we demonstrated inhibition of CREB signaling by Ca(2+)/calmodulin kinase I/IV. These results indicated that GIP acts as a mitogenic and anti-apoptotic factor for beta-cells by pleiotropic activation of tightly linked signaling pathways in beta-cells.
Search for other papers by SA Hinke in
Google Scholar
PubMed
Search for other papers by RP Pauly in
Google Scholar
PubMed
Search for other papers by J Ehses in
Google Scholar
PubMed
Search for other papers by P Kerridge in
Google Scholar
PubMed
Search for other papers by HU Demuth in
Google Scholar
PubMed
Search for other papers by CH McIntosh in
Google Scholar
PubMed
Search for other papers by RA Pederson in
Google Scholar
PubMed
It is well documented that the release of insulin from isolated perifused islets attenuates over time, despite a continued glucose stimulation. In the current study we have shown that potentiation of insulin release by the intestinal hormone glucose-dependent insulinotropic polypeptide (GIP) is also attenuated after its continuous application. In less than 20 h of maintained stimulus with either hyperglycaemia (11.0 mM glucose) or GIP (10 nM) under hyperglycaemic conditions, insulin release returned to basal values. This was not due to loss of islet viability or reduction in the releasable pool of insulin granules, as 1 mM isobutylmethylxanthine was able to stimulate equivalent insulin release under both conditions. Further examination of chronic GIP desensitization was examined in cultured mouse insulinoma (betaTC-3) cells. GIP-stimulated cAMP production was not greatly affected by the prevailing glucose conditions, suggesting that the glucose dependence of GIP-stimulated insulin release occurs distally to the increase in intracellular cAMP in betaTC-3 cells. The GIP-stimulated cAMP response curve after desensitization was of similar magnitude at all glucose concentrations, but GIP pretreatment did not affect forskolin-stimulated cAMP production. Desensitization of the cAMP response in betaTC-3 cells was shown not to involve induction of dipeptidyl peptidase IV or pertussis toxin-sensitive G-proteins, activation of protein kinase C or protein kinase A, or modulation of phosphodiesterase activity. Homologous desensitization of the insulin-potentiating activity of GIP was found to affect both GIP-stimulated and forskolin-stimulated insulin release, indicating desensitization of distal steps in the stimulus-exocytosis cascade.
Search for other papers by VA Gault in
Google Scholar
PubMed
Search for other papers by JC Parker in
Google Scholar
PubMed
Search for other papers by P Harriott in
Google Scholar
PubMed
Search for other papers by PR Flatt in
Google Scholar
PubMed
Search for other papers by FP O'Harte in
Google Scholar
PubMed
The incretin hormone glucose-dependent insulinotropic polypeptide (GIP) is rapidly degraded in the circulation by dipeptidyl peptidase IV forming the N-terminally truncated peptide GIP(3-42). The present study examined the biological activity of this abundant circulating fragment peptide to establish its possible role in GIP action. Human GIP and GIP(3-42) were synthesised by Fmoc solid-phase peptide synthesis, purified by HPLC and characterised by electrospray ionisation-mass spectrometry. In GIP receptor-transfected Chinese hamster lung fibroblasts, GIP(3-42) dose dependently inhibited GIP-stimulated (10(-7) M) cAMP production (up to 75.4+/-5.4%; P<0.001). In BRIN-BD11 cells, GIP(3-42) was significantly less potent at stimulating insulin secretion (1.9- to 3.2-fold; P<0.001), compared with native GIP and significantly inhibited GIP-stimulated (10(-7) M) insulin secretion with maximal inhibition (48.8+/-6.2%; P<0.001) observed at 10(-7) M. In (ob/ob) mice, administration of GIP(3-42) significantly inhibited GIP-stimulated insulin release (2.1-fold decrease; P<0.001) and exaggerated the glycaemic excursion (1.4-fold; P<0.001) induced by a conjoint glucose load. These data indicate that the N-terminally truncated GIP(3-42) fragment acts as a GIP receptor antagonist, moderating the insulin secreting and metabolic actions of GIP in vivo.
Search for other papers by R. M. Elliott in
Google Scholar
PubMed
Search for other papers by L. M. Morgan in
Google Scholar
PubMed
Search for other papers by J. A. Tredger in
Google Scholar
PubMed
Search for other papers by S. Deacon in
Google Scholar
PubMed
Search for other papers by J. Wright in
Google Scholar
PubMed
Search for other papers by V. Marks in
Google Scholar
PubMed
ABSTRACT
The acute effects of different macronutrients on the secretion of glucagon-like peptide-1(7–36)amide (GLP-1(7–36)amide) and glucose-dependent insulinotropic polypeptide (GIP) were compared in healthy human subjects. Circulating levels of the two hormones were measured over a 24-h period during which subjects consumed a mixed diet. In the first study, eight subjects consumed three equicaloric (375 kcal) test meals of carbohydrate, fat and protein. Small increases in plasma GLP-1(7–36) amide were found after all meals. Levels reached a maximum 30 min after the carbohydrate and 150 min after the fat load. Ingestion of both carbohydrate and fat induced substantial rises in GIP secretion, but the protein meal had no effect. In a second study, eight subjects consumed 75 g glucose or the equivalent portion of complex carbohydrate as boiled brown rice or barley. Plasma GIP, insulin and glucose levels increased after all three meals, the largest increase being observed following glucose and the smallest following the barley meal. Plasma GLP-1(7–36)amide levels rose only following the glucose meal. In the 24-h study, plasma GLP-1(7–36)amide and GIP concentrations were increased following every meal and remained elevated throughout the day, only falling to fasting levels at night. The increases in circulating GLP-1(7–36)amide and GIP levels following carbohydrate or a mixed meal are consistent with their role as incretins. The more sustained rises observed in the daytime during the 24-h study are consistent with an anabolic role in lipid metabolism.
Journal of Endocrinology (1993) 138, 159–166
Search for other papers by Christine M A Martin in
Google Scholar
PubMed
Search for other papers by Vadivel Parthsarathy in
Google Scholar
PubMed
Search for other papers by Varun Pathak in
Google Scholar
PubMed
Search for other papers by Victor A Gault in
Google Scholar
PubMed
Search for other papers by Peter R Flatt in
Google Scholar
PubMed
Search for other papers by Nigel Irwin in
Google Scholar
PubMed
Introduction Xenin-25 is a 25 amino acid gastrointestinal hormone secreted from the same enteroendocrine K-cells from which the incretin hormone glucose-dependent insulinotropic polypeptide (GIP) is secreted ( Anlauf et al . 2000 ). Key advances in
Search for other papers by Hidetada Ogata in
Google Scholar
PubMed
Departments of Endocrinology and Diabetes, Metabolic Medicine, Department of Diabetes, Department of Oral and Maxillofacial Surgery, Research Center of Health, Division of Stress Adaptation and Recognition, Department of Medical Physiology, Division of Molecular and Metabolic Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan
Search for other papers by Yusuke Seino in
Google Scholar
PubMed
Search for other papers by Norio Harada in
Google Scholar
PubMed
Search for other papers by Atsushi Iida in
Google Scholar
PubMed
Search for other papers by Kazuyo Suzuki in
Google Scholar
PubMed
Departments of Endocrinology and Diabetes, Metabolic Medicine, Department of Diabetes, Department of Oral and Maxillofacial Surgery, Research Center of Health, Division of Stress Adaptation and Recognition, Department of Medical Physiology, Division of Molecular and Metabolic Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan
Search for other papers by Takako Izumoto in
Google Scholar
PubMed
Search for other papers by Kota Ishikawa in
Google Scholar
PubMed
Search for other papers by Eita Uenishi in
Google Scholar
PubMed
Departments of Endocrinology and Diabetes, Metabolic Medicine, Department of Diabetes, Department of Oral and Maxillofacial Surgery, Research Center of Health, Division of Stress Adaptation and Recognition, Department of Medical Physiology, Division of Molecular and Metabolic Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan
Search for other papers by Nobuaki Ozaki in
Google Scholar
PubMed
Search for other papers by Yoshitaka Hayashi in
Google Scholar
PubMed
Search for other papers by Takashi Miki in
Google Scholar
PubMed
Search for other papers by Nobuya Inagaki in
Google Scholar
PubMed
Search for other papers by Shin Tsunekawa in
Google Scholar
PubMed
Search for other papers by Yoji Hamada in
Google Scholar
PubMed
Search for other papers by Susumu Seino in
Google Scholar
PubMed
Search for other papers by Yutaka Oiso in
Google Scholar
PubMed
Introduction Incretins, the gut hormones such as glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP1), which are secreted from enteroendocrine K-cells and L-cells, respectively, following meal ingestion stimulate
Search for other papers by Ashley I Taylor in
Google Scholar
PubMed
Search for other papers by Nigel Irwin in
Google Scholar
PubMed
Search for other papers by Aine M McKillop in
Google Scholar
PubMed
Search for other papers by Steven Patterson in
Google Scholar
PubMed
Search for other papers by Peter R Flatt in
Google Scholar
PubMed
Search for other papers by Victor A Gault in
Google Scholar
PubMed
et al . 2003 ), and that it is secreted from the same K cell as the incretin hormone glucose-dependent insulinotropic polypeptide (GIP), the possibility of xenin functioning in an incretin-like context is also conceivable. Therefore, the present study
